Tucotuzumab celmoleukin

From Self-sufficiency
Jump to: navigation, search
Tucotuzumab celmoleukin
Monoclonal antibody
Type Whole antibody
Source Template:Infobox drug/mab source
Target EpCAM
Identifiers
CAS Number 339986-90-2
ATC code none
Chemical data
Formula C7812H12124N2044O2408S60
Molar mass 175.1 kDa[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Tucotuzumab celmoleukin is an anti-cancer drug. It is a fusion protein of a humanized monoclonal antibody (tucotuzumab) and an interleukin-2 (celmoleukin).[1][2][3]

This drug was developed by EMD Pharmaceuticals.

References

  1. Statement On A Nonproprietary Name Adopted By The Usan Council - Tucotuzumab Celmoleukin, American Medical Association.
  2. ClinicalTrials.gov
  3. National Cancer Institute: Definition of tucotuzumab celmoleukin